| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Chief Corp. Dev. Officer
1 company
Virani Shafique is a Chief Business Officer at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $492K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 18,000 | $10.93 | $196,740.00 | -11.6% | -27.6% | -40.3% | |
| Dec 15, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 18,000 | $9.60 | $172,800.00 | -11.6% | +11.1% | -28.4% | |
| Nov 15, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 18,000 | $6.51 | $117,180.00 | -11.4% | +36.4% | -3.8% | |
| Oct 16, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 18,000 | $6.30 | $113,400.00 | -11.4% | +64.3% | +1.8% | |
| Sep 15, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 18,000 | $8.66 | $155,880.00 | -11.4% | +11.2% | -23.3% | |
| Aug 15, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 18,000 | $9.25 | $166,500.00 | -11.4% | -36.6% | -31.7% | |
| Jul 26, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 40,000 | $14.36 | $574,200.00 | -12.2% | -55.5% | -40.9% | |
| Jul 18, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 60,000 | $12.73 | $763,800.00 | -17.2% | -51.9% | -38.7% | |
| Jun 16, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 60,000 | $9.54 | $572,400.00 | -17.2% | -3.6% | +3.8% | |
| Jun 2, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Business Officer | Sell | 42,865 | $8.73 | $374,034.45 | -12.3% | +5.7% | +0.6% |